Page last updated: 2024-08-22

nitracrine and Pancreatic Neoplasms

nitracrine has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustin, E; Borowa-Mazgaj, B; Mazerska, Z; Mróz, A; Paluszkiewicz, E	1

Other Studies

1 other study(ies) available for nitracrine and Pancreatic Neoplasms

Article	Year
The overexpression of CPR and P450 3A4 in pancreatic cancer cells changes the metabolic profile and increases the cytotoxicity and pro-apoptotic activity of acridine antitumor agent, C-1748. Biochemical pharmacology, 2017, 10-15, Volume: 142 Topics: Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP3A; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Humans; Membrane Potential, Mitochondrial; NADPH-Ferrihemoprotein Reductase; Nitracrine; Pancreatic Neoplasms; Transfection; Up-Regulation	2017

Article

Year

The overexpression of CPR and P450 3A4 in pancreatic cancer cells changes the metabolic profile and increases the cytotoxicity and pro-apoptotic activity of acridine antitumor agent, C-1748.

Biochemical pharmacology, 2017, 10-15, Volume: 142

Topics: Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP3A; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Humans; Membrane Potential, Mitochondrial; NADPH-Ferrihemoprotein Reductase; Nitracrine; Pancreatic Neoplasms; Transfection; Up-Regulation

2017